Fintech

Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

Globenewswire·March 27, 2026 at 12:00 PM

SOUTH SAN FRANCISCO, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology...

Original Source

Globenewswire — www.globenewswire.com

Related in Fintech

Kalshi sued over alleged illegal gambling
PYMNTS
Coinbase Fixes Unwanted Prediction Market Notifications
PYMNTS
AI Risks Sink Cybersecurity Stocks
PYMNTS
AI upgrades Hollywood's classic films
PYMNTS

Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

Kalshi sued over alleged illegal gambling

Coinbase Fixes Unwanted Prediction Market Notifications

AI Risks Sink Cybersecurity Stocks

AI upgrades Hollywood's classic films